Companies: 10,795·Total market cap: $144.5T
LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRXNASDAQHealthcare● Active
$28.53
$-0.37(-1.28%)
Market Cap$818144882
P/E Ratio
52W High$33.47
52W Low$13.36
Overview

LB Pharmaceuticals Inc Common Stock (LBRX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LBRX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-21.47lbrx eps ttm · lbrx earnings per shareEarnings history
PE Ratio (TTM)lbrx pe ratio ttm · lbrx price to earningsPE Ratio deep dive
Revenue (TTM)0.00lbrx revenue ttm · lbrx annual revenueFull revenue history
Dividend YieldNo Dividenddoes lbrx pay dividends · lbrx dividend yieldDividend history
Shares Outstanding25.3Mlbrx shares outstanding · lbrx floatShares outstanding history
Next EarningsAug 11, 2026Est.lbrx earnings date · lbrx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
lb pharmaceuticals inc common stock revenue · lbrx revenue 2025
FY 2025Net Income-$25.2M▲ +60.06% YoY
202320242025
lb pharmaceuticals inc common stock net income · lbrx profit 2025
FY 2025EPS$-1.00▲ +94.39% YoY
202320242025
lbrx eps · lb pharmaceuticals inc common stock earnings per share 2025
TTM:Revenue: $0.00Net Income: -$39.2MEPS: $-21.47View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis lbrx a buy · lbrx analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$36.00Low
$28.53Current
$39.50Avg Target38.45% upside
$45.00High
lbrx price target · lbrx 12 month forecast

Total: 1 · Buy rate: 100.0%

The LBRX analyst consensus is Buy, based on ratings from 1 Wall Street analysts over the past 3 months. The average 12-month price target is $39.50, representing +38.45% upside from the current price of $28.53.

Stock Performance

Full History
1D-1.28%
1W+5.59%
1M-10.76%
3M+19.97%
YTD+28.17%
1Y+64.91%
5Y+64.91%

About LB Pharmaceuticals Inc Common Stock

CEOHeather D. Turner
IPO DateSep 11, 2025
Employees16
CountryUS

LB Pharmaceuticals Inc Common Stock Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulp…

what is lb pharmaceuticals inc common stock · lbrx stock overview · lb pharmaceuticals inc common stock company profile · who is lb pharmaceuticals inc common stock ceo · lbrx NASDAQ · lb pharmaceuticals inc common stock headquarters · lb pharmaceuticals inc common stock business segments

About Stock Overview & Key Data

LB Pharmaceuticals Inc Common Stock (LBRX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 11, 2025. As of the latest trading session, LBRX stock price is $28.53, with a market capitalization of $818.1M. The stock has returned +64.91% over the past 12 months and +28.17% year-to-date.

According to 1 Wall Street analysts, the consensus rating for LB Pharmaceuticals Inc Common Stock stock is Buy, with an average 12-month price target of $39.50. In fiscal year 2025, LB Pharmaceuticals Inc Common Stock reported revenue of — and net income of -$25.2M. For detailed data — including LB Pharmaceuticals Inc Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, LB Pharmaceuticals Inc Common Stock (LBRX) stock price is $28.53. The stock is traded on NASDAQ under the ticker symbol LBRX. The 52-week range is $13.36 – $33.47.

LBRX stock priceLBRX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice